Robert A. (Hrsg.) Figlin

Kidney Cancer

Buch

Kidney cancer is a heterogenous disease. This book covers: -new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques; -new staging and prognostic capabilities; -evolving therapeutic options include, cell based vaccine, gene and antibody therapy; -molecular genetics allow for a better understanding of the various types of kidney cancer. Kidney Cancer is a comprehensive review covering present and future surgical approaches, staging and prognostic factors, currently accepted and future plans for prevention, diagnosis and treatment. Contributing authors to this book are internatio… Mehr

CHF 211.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V104: Folgt in ca. 10 Arbeitstagen

Produktdetails

ISBN: 978-1-4020-7457-8
EAN: 9781402074578
Produktnummer: 1707515
Verlag: Springer Us
Sprache: Englisch
Erscheinungsjahr: 2003
Seitenangabe: 260 S.
Masse: H24.1 cm x B16.0 cm x D1.9 cm 559 g
Auflage: 2003
Abbildungen: HC runder Rücken kaschiert
Gewicht: 559

Über den Autor

Robert A. Figlin, Professor of Medicine, Urology, Departments of Medicine and Urology, Division of Hematology/Oncology, University of California, Los Angeles School of Medicine, USA, holds the Henry Alvin and Carrie L. Meinhardt Chair in Urologic Oncology. He serves as Medical Director of the Thoracic and Genitourinary Oncology Program. He is a Senior Clinical Investigator in areas of genitourinary and thoracic oncology and has served as Principal Investigator on Phase I, II, and III trials. He serves as Chairman of the UCLA Medical Institutional Review Board and as a member of the UCLA Human Research Policy Board.